DE60128252D1 - Membranfraktionen von mit 1,2-sn-Diacylglycerol angereicherten Zellen - Google Patents

Membranfraktionen von mit 1,2-sn-Diacylglycerol angereicherten Zellen

Info

Publication number
DE60128252D1
DE60128252D1 DE60128252T DE60128252T DE60128252D1 DE 60128252 D1 DE60128252 D1 DE 60128252D1 DE 60128252 T DE60128252 T DE 60128252T DE 60128252 T DE60128252 T DE 60128252T DE 60128252 D1 DE60128252 D1 DE 60128252D1
Authority
DE
Germany
Prior art keywords
diacylglycerol
membrane fractions
cells enriched
mgdg synthase
enriched
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60128252T
Other languages
English (en)
Other versions
DE60128252T2 (de
Inventor
Eric Marechal
Stephane Miras
Jacques Joyard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
Original Assignee
Centre National de la Recherche Scientifique CNRS
Commissariat a lEnergie Atomique CEA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Commissariat a lEnergie Atomique CEA filed Critical Centre National de la Recherche Scientifique CNRS
Application granted granted Critical
Publication of DE60128252D1 publication Critical patent/DE60128252D1/de
Publication of DE60128252T2 publication Critical patent/DE60128252T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/16—Enzymes or microbial cells immobilised on or in a biological cell
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60128252T 2000-10-31 2001-10-26 Membranfraktionen von mit 1,2-sn-Diacylglycerol angereicherten Zellen Expired - Lifetime DE60128252T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0013976 2000-10-31
FR0013976A FR2815968B1 (fr) 2000-10-31 2000-10-31 Fractions membranaires de cellules enrichies en 1,2-sn- diacylglycerol, procede de preparation et utilisations
PCT/FR2001/003329 WO2002036811A1 (fr) 2000-10-31 2001-10-26 Fractions membranaires de cellules enrichies en 1,2-sn-diacylglycerol

Publications (2)

Publication Number Publication Date
DE60128252D1 true DE60128252D1 (de) 2007-06-14
DE60128252T2 DE60128252T2 (de) 2008-01-10

Family

ID=8855938

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60128252T Expired - Lifetime DE60128252T2 (de) 2000-10-31 2001-10-26 Membranfraktionen von mit 1,2-sn-Diacylglycerol angereicherten Zellen

Country Status (9)

Country Link
US (1) US7435583B2 (de)
EP (1) EP1330537B1 (de)
JP (1) JP4024147B2 (de)
AT (1) ATE361376T1 (de)
AU (2) AU2002214113B2 (de)
CA (1) CA2427267A1 (de)
DE (1) DE60128252T2 (de)
FR (1) FR2815968B1 (de)
WO (1) WO2002036811A1 (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2790915B1 (fr) * 1999-03-19 2001-06-01 Commissariat Energie Atomique Procede de criblage et de selection d'antiparasitaires apicomplexes et/ou d'herbicides et ses applications

Also Published As

Publication number Publication date
JP2004529612A (ja) 2004-09-30
AU2002214113B2 (en) 2006-02-23
US20040013739A1 (en) 2004-01-22
EP1330537B1 (de) 2007-05-02
DE60128252T2 (de) 2008-01-10
EP1330537A1 (de) 2003-07-30
ATE361376T1 (de) 2007-05-15
WO2002036811A1 (fr) 2002-05-10
AU1411302A (en) 2002-05-15
JP4024147B2 (ja) 2007-12-19
FR2815968A1 (fr) 2002-05-03
FR2815968B1 (fr) 2005-01-07
CA2427267A1 (fr) 2002-05-10
US7435583B2 (en) 2008-10-14

Similar Documents

Publication Publication Date Title
CY1112101T1 (el) Νευροτροφικοι παραγοντες
TR199902426T2 (xx) Bitki b�ceklerinin kontrol�.
ATE368054T1 (de) Verbindungen und methoden zur modulierung von occludin-abhängiger gewebepermeabilität
DE69942459D1 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
ATE408422T1 (de) Methode zur hemmung immunstimulatorischer mit dna assoziierter antworten
DE69435307D1 (de) Bazillus Thuringiensis und dessen insektizide Proteine
BR0207775A (pt) Lipossomos anfotéricos métodos para carregamento dos mesmos com ingredientes ativos e sua utilização
SE9802729D0 (sv) Novel Compounds
ATE415480T1 (de) B7l-1 moleküle
EE04685B1 (et) Ravimi l„bimiskiirust kontrolliv membraan v?i maatriks
DE60138715D1 (de) Tnf-rezeptor-ähnliche moleküle und deren anwendungen
DE69534551D1 (de) Neue methode zum auffindenund bewerten biologisch aktiver moleküle
DE60044655D1 (de) Angereicherte Zellpopulationen des zentralen Nervensystems
DK1082423T3 (da) Cyclin E2-gener og -proteiner
ATE439441T1 (de) Veränderte, fluoreszierende proteine
IS7154A (is) Bv8 kjarnsýrur og fjölpeptíð með mítósu-valdandi verkun
MXPA05009743A (es) Composiciones con actividad hematopoyetica e inmune.
DE60027735D1 (de) Genetische screeningverfahren
ATE291586T1 (de) Humanes antibiotisches protein
BR0008187A (pt) Controle biológico de nematódeos
ATE361376T1 (de) Membranfraktionen von mit 1,2-sn-diacylglycerol angereicherten zellen
DK0939769T3 (da) Vertebrat-Smoothened-proteiner
ATE294862T1 (de) Humane sel-10 polypeptiden und dafur kodierende polynukleotiden
NO971553L (no) Cytoplasmisk tyrosinkinase
WO2003012102A3 (fr) Acides nucleiques codant des proteines a domaine hect

Legal Events

Date Code Title Description
8364 No opposition during term of opposition